Retinopathy of prematurity: Any difference in risk factors between a high and low risk population?

European Journal of Ophthalmology

Volumn 13, Issue 9-10, 2003, Pages 784-788

  Allegaert, K ^a   Casteels, I ^a   Cossey, V ^a   Devlieger, H ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Clinical Risk Index for Babies (CRIB); Creatinemia; Retinopathy of prematurity; Risk factor

Indexed keywords

DOPAMINE; OXYGEN;

APGAR SCORE; ARTICLE; BIRTH WEIGHT; CHI SQUARE DISTRIBUTION; DISEASE SEVERITY; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MICROANGIOPATHY; OXYGENATION; PRIORITY JOURNAL; RANK SUM TEST; RETROLENTAL FIBROPLASIA; RISK FACTOR;

EID: 1042290359     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/1120672103013009-1009     Document Type: Article

References (14)

1. Weathley CM, Dickinson JL, Mackey DA, Craig JE, Sale MM. Retinopathy of prematurity: recent advances in our understanding. Br J Ophthalmol 2002; 86: 696-700.
2. Allegaert K, Verdonck N, Vanhole C, et al. Incidence, perinatal risk factors, visual outcome and management of threshold retinopathy. Bull Soc Belge Ophtalmol 2003; 287: 37-42.
3. The International Neonatal Network. The CRIB (Clinical Risk Index for Babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 1993; 342: 193-8.
4. Buhrer C, Grimmer I, Metze B, Obladen M. The CRIB (Clinical Risk Index for Babies) score and neurodevelopmental impairment at one year corrected age in very low birth-weight infants. Intens Care Med 2000; 26: 325-9.
5. Lago P, Freato F, Bettiol T, Chiandetti L, Vianello A, Zaramella P. Is the CRIB score (Clinical Risk Index for Babies) a valid tool in predicting neurodevelopmental outcome in extremely low birthweight infants? Biol Neonate 1999; 76: 220-7.
6. International Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984; 102: 1130-4.
7. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics 1999; 104: e26.
8. Bullard SR, Donahue SP, Feman SS, Sinatra RB, Walsh WF. The decreasing incidence and severity of retinopathy of prematurity. J AAPOS 1999; 3: 46-52.
9. The Italian ROP Study Group. Italian multicentre study on retinopathy of prematurity. Eur J Pediatr 1997; 156: 939-43.
10. Asproudis IC, Andronikou SK, Hotoura EA, Kalogeropoulos CD, Kitsos GK, Psilas KE. Retinopathy of prematurity and other ocular problems in premature infants weighing less than 1500 g at birth. Eur J Ophthalmol 2002; 12: 506-11.
11. Allegaert K, de Coen K, Devlieger H, the EPIBEL Study Group. Threshold retinopathy at threshold of viability: the EpiBel study. Br J Ophthalmol 2003 (in press).
12. Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications. Horm Res 2000; 53: 53-67.
13. Yang B, Cross DF, Ollerenshaw M, et al. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complications 2003; 17: 1-6.
14. Stout AU, Stout JT. Retinopathy of prematurity. Pediatr Clin N Am 2003; 50: 77-87.